大会分两个阶段进行。主题大会与专场活动（9月11日-12日），将发布高校院所科技成果4100余项、企 业技术需求3600余项，组织4000余家企业对接洽谈。揭牌材料领域全国实验室联盟，发布"科创未来之 星"榜单，并举办4个专场活动和10场路演。除此之外还将组织160余位产业专家赴500余家企业实地考 察，开展技术咨询、现场洽谈，推动合作下沉至地方产业一线。 2025年9月1日，江苏省科技厅召开新闻发布会，宣布2025江苏产学研合作对接大会将于9月11日至12日 在南京国际展览中心开幕。本次大会由省科技厅主办、省新质生产力促进中心承办，以"科技赋能新质 生产力 创新融合发展打头阵"为主题，旨在推动科技创新与产业创新深度融合，加速科技成果转化，助 力江苏打造具有全球影响力的产业科技创新中心。 本届大会呈现三大特色。嘉宾层级高、领域广：已邀请科技部、中国科学院等部委领导，985高校及省 内外科研院所负责人，两院院士、全国重点实验室主任等180余名高层次专家参会，其中包括2名诺贝尔 奖获得者、50余名院士。重大成果集中亮相：将发布近三年江苏产业科技创新标志性成果200余项，涵 盖人工智能、生物医药、集成电路等领域。入 ...

Core Viewpoint - Xinhecheng (002001.SZ) announced a share buyback program, repurchasing a total of 14,299,692 shares, which represents 0.4653% of the company's total share capital, with a total transaction amount of 309,114,666.59 yuan [1] Summary by Relevant Sections - **Share Buyback Details** - The company repurchased shares through a dedicated securities account via centralized bidding [1] - The highest transaction price was 22.23 yuan per share, while the lowest was 21.25 yuan per share [1] - The total amount spent on the buyback was 309,114,666.59 yuan, excluding transaction fees [1] - **Compliance and Regulations** - The buyback aligns with the company's established share repurchase plan and complies with relevant laws and regulations [1]

浙江新和成股份有限公司 关于回购公司股份进展的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江新和成股份有限公司（以下简称"公司"）于2025年4月11日召开的第 九届董事会第十一次会议审议通过《关于回购公司股份方案的议案》，同意公司 使用自有资金或回购专项贷款以集中竞价交易的方式回购公司部分社会公众股 份，用于实施股权激励计划或员工持股计划。本次回购金额区间为30,000万元 -60,000万元，回购价格不超过人民币32元/股，具体回购股份的数量及占总股本 的比例以回购期满时实际回购数量为准。本次回购股份的实施期限为自公司董事 会审议通过回购股份方案之日起不超过12个月。 根据公司披露的《关于回购公司股份方案的公告》《回购股份报告书》（公告 编号：2025-010、2025-023）相关规定，若公司在回购期间内发生资本公积转增 股本、派发红利、送红股等除权除息事宜，自股价除权除息之日起，按照中国证 监会及深圳证券交易所的相关规定相应调整回购价格。公司 2025 年 5 月 21 日实 施 2024 年年度权益分派，回购价格由不超过人民币 32 元/ ...

Investment Rating - The report rates the chemical industry as "Outperforming the Market" [2] Core Views - The report highlights the impact of rising international oil prices and hydrogen fluoride prices, while TDI prices have decreased. It suggests focusing on mid-year report trends, the influence of "anti-involution" on supply in related sub-industries, and the importance of self-sufficiency in electronic materials companies [2][3] - The report recommends investment in energy companies with stable dividend policies and emphasizes the potential for high profitability in the oil and gas extraction sector due to expected sustained high oil prices [3] Summary by Sections Industry Dynamics - As of August 31, the TTM price-to-earnings ratio for the SW basic chemicals sector is 25.77, at the 82.14 percentile historically, while the price-to-book ratio is 2.23, at the 54.61 percentile. For the SW oil and petrochemical sector, the TTM price-to-earnings ratio is 11.87, at the 28.30 percentile historically, and the price-to-book ratio is 1.17, at the 23.58 percentile [3][10] - The report notes significant fluctuations in the industry due to tariff policies and oil price volatility, suggesting a focus on mid-year earnings reports and the impact of supply-side changes in various sub-industries [3][10] Investment Recommendations - The report recommends focusing on the following investment themes: 1. Sustained high oil prices are expected to benefit the oil and gas extraction sector, with increased capital expenditure in upstream oil and gas and a recovery in the oil service industry [3] 2. Rapid development in downstream industries, particularly in new materials, with significant growth potential in electronic materials and renewable energy materials [3] 3. Policy support is expected to drive demand recovery, with a focus on leading companies with performance elasticity and high-growth sub-industries [3][10] Key Stocks to Watch - Recommended stocks include China Petroleum, China National Offshore Oil Corporation, China Petrochemical Corporation, and several technology and chemical companies such as Anji Technology and Yake Technology [3][10]

Economic News - The Central Committee of the Communist Party of China and the State Council published opinions on promoting high-quality urban development, aiming for significant progress by 2030 and basic completion by 2035 [2] - The U.S. has revoked the VEU exemptions for Samsung, SK Hynix, and Intel in China, potentially tightening the global semiconductor supply chain [2] - Foreign capital is increasing investments in Chinese assets, with major banks like JPMorgan and Citigroup boosting their holdings in companies like CATL and ZTE [2] - Central Huijin has significantly increased its holdings in ETFs, spending over 210 billion yuan on 12 ETF products, reaching a total market value of 1.28 trillion yuan [2] - The summer box office has surpassed last year, with total box office revenue reaching 11.65 billion yuan, exceeding the previous year's figures [2] - The Ministry of Industry and Information Technology is promoting satellite communication, aiming for significant advancements by 2030 [2] Company Insights - Luzhou Laojiao reported a revenue of 16.454 billion yuan and a net profit of 7.663 billion yuan in the first half of the year, showcasing resilience amid industry adjustments [6] - Maiwei Biotech experienced a net loss of 555 million yuan in the first half, with a focus on its innovative drug business as a key driver [6] - Zhejiang Zhenyuan's new industrial base has been inaugurated, marking a significant step in its operational expansion [6] - Xidi Micro reported a revenue of 466 million yuan, a 102.73% increase year-on-year, despite a net loss of 44.69 million yuan [7] - Lushan New Materials achieved a revenue of 741 million yuan, with a net profit of 15.94 million yuan, driven by strong demand for its polyolefin functional materials [7] Daily Research Reports - Anhui Expressway reported a revenue of 3.741 billion yuan, a year-on-year increase of 11.7%, with net profit reaching 960 million yuan [8] - The newly acquired assets have started contributing profits, with significant revenue recovery expected from the Xuan Guang and Guang Ci highways [9] - The overall performance of the company's main road assets showed steady growth, with notable increases in toll revenues from various highways [10] Industry Ratings - New Hope Liuhe is expected to maintain strong performance, with projected net profits of 19.3 billion yuan, 20.0 billion yuan, and 18.6 billion yuan for 2025-2027 [11][12] - Xinhecheng reported a revenue of 11.101 billion yuan, a 12.76% increase, and a net profit of 3.603 billion yuan, a 63.46% increase, driven by rising prices in core products [14][15] - Ganyuan Foods faced a revenue decline of 9.34% to 945 million yuan, with a significant drop in net profit due to market pressures and inventory accumulation [18][19]

Core Insights - Heilongjiang Province is positioned as a strategic hub in the "Belt and Road" initiative, particularly in the China-Mongolia-Russia Economic Corridor, with significant potential for cooperation in the new materials industry and technology [1][2] - The province has a strong resource endowment, industrial foundation, educational resources, geographical advantages, and diverse application scenarios for developing the new materials industry [1][2] Industry Development - The province has discovered 149 types of mineral resources, with crystalline graphite reserves of 379 million tons, accounting for over 53.7% of the national total, ranking first in the country [1] - Molybdenum reserves are 2.687 million tons, placing Heilongjiang fifth nationally [1] Investment Promotion - The investment promotion event aimed to showcase the advantages of Heilongjiang's new materials industry, investment projects, and business environment, facilitating collaboration among innovation, industry, capital, and talent chains [1][2] - Various enterprises, including China Nonferrous Mining Group and others, shared their investment experiences and future plans in Heilongjiang, providing targeted suggestions for the development of the new materials industry [2] Policy and Collaboration - Heilongjiang is mobilizing resources from government, industry, academia, and research to enhance the quality and scale of its industries, achieving solid results in innovation, scale, transformation, and cluster development [2]

Group 1 - The company, Xinhecheng, stated on August 30 that it currently does not have a cholesterol production line [1]

Group 1 - The company does not currently have a cholesterol production line [2] - An investor inquired about the progress and expected production date of a 500 tons/year cholesterol production line project [2]

Core Viewpoint - The company has demonstrated robust growth in its financial performance and is actively pursuing various projects to enhance its market presence and product offerings [1][2][3] Financial Performance - In the first half of 2025, the company reported revenue of 11.1 billion yuan, a year-on-year increase of 12.76% - Total profit reached 4.229 billion yuan, reflecting a 56.68% increase compared to the previous year - Net profit attributable to shareholders was 3.603 billion yuan, up 63.46% year-on-year [1] Project Progress - The liquid methionine project, a joint venture with Sinopec, has entered trial production, with plans for maintenance in early September - The new materials segment generated revenue of 1.038 billion yuan, a 43.75% increase, driven by demand in the new energy sector - The Tianjin nylon new materials project is in the approval stage, with production expected to start in 2027 - The flavor and fragrance segment reported revenue of 2.105 billion yuan in the first half of 2025, with ongoing efforts to optimize product structure [2] Business Strategy and Market Expansion - The company is enhancing production capacity in the nutrition sector and expanding into cutting-edge biotechnology, including amino acids and new materials - Products are being exported to over 100 countries, with an export ratio of 58.04% in the first half of 2025 - Future investment will focus on the new materials sector, including the Tianjin nylon project and new biopharmaceutical products in the vitamin segment [3] Shareholder Returns - The company maintains a stable profit distribution policy, with cumulative dividends amounting to 15.5 billion yuan, representing 30% to 50% of annual net profit - A cash dividend of 2 yuan per 10 shares is proposed for the first half of 2025, totaling 612 million yuan, pending shareholder approval [3]

Financial Performance - The company achieved a revenue of 11.1 billion CNY, representing a year-on-year growth of 12.76% [3] - The total profit reached 4.2 billion CNY, marking a significant increase of 56.68% compared to the previous year [3] - Net profit attributable to shareholders was 3.6 billion CNY, reflecting a growth of 36.03% [3] Business Segments - The liquid methionine project is in trial production, with a capacity of 180,000 tons/year, and is expected to undergo maintenance for 3-4 weeks [3] - The new materials segment generated a revenue of 1.038 billion CNY, up 43.75% year-on-year, driven by demand in new energy and high-end manufacturing [4] - The fragrance and flavor segment reported a revenue of 2.105 billion CNY, with plans for product optimization and expansion [4] Strategic Initiatives - The company is focusing on international expansion, with exports accounting for 58.04% of total sales, reaching over 100 countries [6] - Future investments will prioritize new materials, including the nylon project in Tianjin, expected to commence production in 2027 [6] - The company plans to distribute cash dividends of 6.12 CNY per share, totaling 1.5 billion CNY, subject to shareholder approval [8] Market Outlook - The company aims to enhance its competitive edge through innovation and a focus on sustainable development, aligning with the "anti-involution" policy to foster a healthy market environment [8] - The strategic focus will remain on fine chemicals, health nutrition, new materials, and raw pharmaceutical ingredients [6]